China Hormone Replacement Therapy Market Size & Outlook

The hormone replacement therapy market in China is expected to reach a projected revenue of US$ 1,698.9 million by 2030. A compound annual growth rate of 8% is expected of China hormone replacement therapy market from 2023 to 2030.
Revenue, 2022 (US$M)
$916.0
Forecast, 2030 (US$M)
$1,698.9
CAGR, 2023 - 2030
8%
Report Coverage
China

China hormone replacement therapy market, 2018-2030 (US$M)

China

China hormone replacement therapy market highlights

  • The China hormone replacement therapy market generated a revenue of USD 916.0 million in 2022 and is expected to reach USD 1,698.9 million by 2030.
  • The China market is expected to grow at a CAGR of 8% from 2023 to 2030.
  • In terms of segment, estrogen and progesterone replacement therapy was the largest revenue generating product in 2022.
  • Parathyroid Hormone replacement is the most lucrative product segment registering the fastest growth during the forecast period.


Hormone replacement therapy market data book summary

Market revenue in 2022USD 916.0 million
Market revenue in 2030USD 1,698.9 million
Growth rate8% (CAGR from 2022 to 2030)
Largest segmentEstrogen and progesterone replacement therapy
Fastest growing segmentParathyroid Hormone replacement
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationEstrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement
Key market players worldwideEli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc


Other key industry trends

  • In terms of revenue, China accounted for 4.3% of the global hormone replacement therapy market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan hormone replacement therapy market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,698.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hormone Replacement Therapy Market Companies

Name Profile # Employees HQ Website

China hormone replacement therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.


Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 53.41% in 2022. Horizon Databook has segmented the China hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2018 to 2030.


China has been facing the issue of a growing death rate owing to the increasing incidence of diseases related to hormonal imbalance. According to an article published by Frontiers in Endocrinology, (May 2021), the prevalence of different types of hyperthyroidism was as follows: severe subclinical hyperthyroidism (0.22%), overt hyperthyroidism (0.78%), graves’ disease (0.53%), and mild subclinical hyperthyroidism (0.22%).

While it was more prevalent in women than men, the prevalence of hypothyroidism was significantly reduced after 60 years. In addition, increased levels of thyroid peroxidase antibody and thyroglobulin levels were significantly related to the rising prevalence of overt hypothyroidism and graves’ disease.

Reasons to subscribe to China hormone replacement therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China hormone replacement therapy market databook

  • Our clientele includes a mix of hormone replacement therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China hormone replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into China hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China hormone replacement therapy market size, by product, 2018-2030 (US$M)

China Hormone Replacement Therapy Market Outlook Share, 2022 & 2030 (US$M)

China hormone replacement therapy market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more